Relationship between oxidized lipoprotein, angiogenesis and human coronary atherosclerotic plaque stabilization

Chinese Journal of Pathology

Volumn 35, Issue 3, 2006, Pages 138-141

  Wei, Li Xin ^a   Tang, Qing He ^a   Sun, Lu ^a   Shi, Huai Yin ^a   Guo, Ai Tao ^a   You, Lian Bi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Arteriosclerosis; Lipoproteins, LDL; Neovascularization, pathologic

Indexed keywords

BLOOD CLOTTING FACTOR 8; OXIDIZED LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; NEOVASCULARIZATION (PATHOLOGY); PLANIMETRY; QUANTITATIVE ANALYSIS;

ANGINA, UNSTABLE; CORONARY ARTERY DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 33645103580     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shah PK, Moreno P, Falk E. Pathophysiology of plaque rupture. J Vasc Med Biol, 1995, 5: 244-258.
2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation, 1995, 92: 657-671.
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 1995, 92: 1355-1374.
4. Gertz SD, Robert WC. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol, 1990, 66; 1368-1372.
5. de Boer OJ, van der Wal AC, Teeling P, et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res, 1999, 41: 443-449.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362: 801-809.
7. Kristensen SD,Ravn HB, Falk E. Insights into the pathophysiology of unstable coronary artery disease. Am J Cardiol, 1997, 80(5A): 5E-9E.
8. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J, 1993, 69: 377-381.
9. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A, 1989, 86: 1372-1376.
10. Small DM. Progression and regression of atherosclerotic lesion: insight from lipid physical biochemistry. Arteriosclerosis, 1998, 8: 103-109.
11. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001, 103: 1955-1960.
12. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest, 1993, 92: 945-951.
13. Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett, 2001, 495: 159-166.